CRSP icon

CRISPR Therapeutics
CRSP

Overview Fund Activity

387 hedge funds and large institutions have $2.19B invested in CRISPR Therapeutics in 2025 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 119 increasing their positions, 102 reducing their positions, and 59 closing their positions.

Holders
387
Holders Change
-11
Holders Change %
-2.76%
% of All Funds
5.26%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
54
Increased
119
Reduced
102
Closed
59
Calls
$96.3M
Puts
$75.6M
Net Calls
+$20.7M
Net Calls Change
+$30.7M

Top Buyers

1
UBS AM
1
UBS AM
Illinois
$66.5M
2
AIM
2
ARK Investment Management
Florida
$346M
3
Two Sigma Investments
3
Two Sigma Investments
New York
$40.5M
4
Morgan Stanley
4
Morgan Stanley
New York
$44.2M
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$27.1M

Top Sellers

1
WA
1
Whipplewood Advisors
Colorado
$137K
2
Capital International Investors
2
Capital International Investors
California
$207M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$2.84M
4
BBA
4
Baker Bros. Advisors
New York
$22.3M
5
Citadel Advisors
5
Citadel Advisors
Florida
$8.76M
Name Market Value Shares Shares
Change 		Shares
Change %
AIM
1
ARK Investment Management
Florida
$346M 10,165,400 +1,192,336 +13%
Capital International Investors
2
Capital International Investors
California
$207M 6,073,118 -2,670,405 -31%
T. Rowe Price Investment Management
3
T. Rowe Price Investment Management
Maryland
$129M 3,798,103 -13,605 -0.4%
BlackRock
4
BlackRock
New York
$88.9M 2,613,539 -145,787 -5%
Sumitomo Mitsui Trust Group
5
Sumitomo Mitsui Trust Group
Japan
$86.4M 2,539,889 -205,787 -7%
NAMA
6
Nikko Asset Management Americas
New York
$86.3M 2,539,889 -205,787 -7%
State Street
7
State Street
Massachusetts
$82.1M 2,411,262 -80,263 -3%
UBS Group
8
UBS Group
Switzerland
$70.5M 2,071,892 +87,902 +4%
UBS AM
9
UBS AM
Illinois
$66.5M 1,952,751 +1,262,560 +183%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$66M 1,940,545 -282,748 -13%
Vanguard Group
11
Vanguard Group
Pennsylvania
$60.2M 1,769,709 +33,711 +2%
NMC
12
NEA Management Company
Maryland
$54M 1,587,854 – –
OAG
13
Orbis Allan Gray
Bermuda
$53.2M 1,562,932 +86,813 +6%
EC
14
EcoR1 Capital
California
$47.3M 1,389,276 – –
Bank of America
15
Bank of America
North Carolina
$47.2M 1,386,770 +175,261 +14%
Morgan Stanley
16
Morgan Stanley
New York
$44.2M 1,299,982 +804,980 +163%
Two Sigma Investments
17
Two Sigma Investments
New York
$40.5M 1,189,159 +882,887 +288%
SOCM
18
SR One Capital Management
Pennsylvania
$35.7M 1,048,951 – –
Geode Capital Management
19
Geode Capital Management
Massachusetts
$35.6M 1,045,904 +45,036 +4%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$31.9M 937,145 -10,156 -1%
Loomis, Sayles & Company
21
Loomis, Sayles & Company
Massachusetts
$31M 909,792 -1,173 -0.1%
Two Sigma Advisers
22
Two Sigma Advisers
New York
$27.1M 797,200 +712,400 +840%
Charles Schwab
23
Charles Schwab
California
$24.3M 713,539 -9,493 -1%
BBA
24
Baker Bros. Advisors
New York
$22.3M 654,099 -653,912 -50%
Millennium Management
25
Millennium Management
New York
$19.9M 583,733 +575,235 +6,769%
1
2 3 4 5